Does FOSAPREPITANT Cause Hypercholesterolaemia? 56 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Hypercholesterolaemia have been filed in association with FOSAPREPITANT. This represents 11.5% of all adverse event reports for FOSAPREPITANT.
56
Reports of Hypercholesterolaemia with FOSAPREPITANT
11.5%
of all FOSAPREPITANT reports
56
Deaths
56
Hospitalizations
How Dangerous Is Hypercholesterolaemia From FOSAPREPITANT?
Of the 56 reports, 56 (100.0%) resulted in death, 56 (100.0%) required hospitalization, and 56 (100.0%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT Cause?
Dyspnoea (195)
Infusion related reaction (167)
Hypersensitivity (157)
Duodenal ulcer perforation (155)
Confusional state (149)
Glossodynia (149)
Folliculitis (146)
Arthralgia (144)
Blister (144)
Discomfort (144)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which FOSAPREPITANT Alternatives Have Lower Hypercholesterolaemia Risk?
FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE
FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT vs FOSCARNET
FOSAPREPITANT vs FOSFOMYCIN
FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE